Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer

Publication Date: April 26, 2021

Key Points

Key Points

  • The Panel continues to recommend that full, weight-based cytotoxic chemotherapy doses be used to treat obese adults with cancer.
  • The Panel also recommends that full, approved doses of immunotherapy and targeted therapies be offered to obese adults with cancer.
  • In the event of toxicity, the consensus of the Panel is that dose modifications of systemic antineoplastic therapies should be handled similarly for obese and non-obese patients.

Treatment

Treatmen...

...l weight-based dosing of cytotoxic che...


...e Panel recommends limiting fixed dosing of chem...


...ed prescribing information for checkpoint inhibito...


...pproved prescribing information for targeted...


...ent experiences high-grade toxicity from syst...


...recommends that BSA be calculated...